CARDIOVASCULAR RISK

Open Access
Erectile Dysfunction and Cardiovascular Risk in Men With Rheumatoid Arthritis: A Population-based Cohort Study
Katelynn M. Wilton, Sara J. Achenbach, John M. Davis III, Elena Myasoedova, Eric L. Matteson and Cynthia S. Crowson

The Journal of Rheumatology November 1 2021, 48 (11) 1641-1647; DOI: https://doi.org/10.3899/jrheum.201226
You have access
Role of Carotid Ultrasound and Systematic Coronary Risk Evaluation Charts for the Cardiovascular Risk Stratification of Patients with Psoriatic Arthritis
María Paz Martínez-Vidal, Mariano Andrés, Vega Jovaní, Carlos Santos-Ramírez, Cintia Romera and Cristina Fernández-Carballido

The Journal of Rheumatology May 1 2020, 47 (5) 682-689; DOI: https://doi.org/10.3899/jrheum.181223
You have access
Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study
Rabia Agca, Luuk H.G.A. Hopman, Koen J.C. Laan, Vokko P. van Halm, Mike J.L. Peters, Yvo M. Smulders, Jacqueline M. Dekker, Giel Nijpels, Coen D.A. Stehouwer, Alexandre E. Voskuyl, Maarten Boers, Willem F. Lems and Michael T. Nurmohamed

The Journal of Rheumatology March 1 2020, 47 (3) 316-324; DOI: https://doi.org/10.3899/jrheum.180726
You have access
The Effects of 5-year Etanercept Therapy on Cardiovascular Risk Factors in Patients with Psoriatic Arthritis
Rabia Agca, Maaike Heslinga, Eva L. Kneepkens, Carlo van Dongen and Michael T. Nurmohamed

The Journal of Rheumatology September 1 2017, 44 (9) 1362-1368; DOI: https://doi.org/10.3899/jrheum.161418
You have access
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano, Luciana Pierro, Ilenia Pantano, Michele Iudici and Gabriele Valentini

The Journal of Rheumatology July 1 2017, 44 (7) 1032-1038; DOI: https://doi.org/10.3899/jrheum.161351
You have access
The Relationship Between Cardiac Conduction Times, Cardiovascular Risk Factors, and Inflammation in Patients with Early Arthritis
Samina A. Turk, Sjoerd C. Heslinga, Jill Dekker, Linda Britsemmer, Véronique van der Lugt, Willem F. Lems, Dirkjan van Schaardenburg and Michael T. Nurmohamed

The Journal of Rheumatology May 1 2017, 44 (5) 580-586; DOI: https://doi.org/10.3899/jrheum.161184
You have access
Increased Prevalence of Diastolic Heart Failure in Patients with Rheumatoid Arthritis Correlates with Active Disease, but Not with Treatment Type
Thomas Schau, Michael Gottwald, Olga Arbach, Martin Seifert, Maren Schöpp, Michael Neuß, Christian Butter and Michael Zänker

The Journal of Rheumatology November 1 2015, 42 (11) 2029-2037; DOI: https://doi.org/10.3899/jrheum.141647
You have access
Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis
Michelle J. Ormseth, Joseph F. Solus, Kasey C. Vickers, Annette M. Oeser, Paolo Raggi and C. Michael Stein

The Journal of Rheumatology October 1 2015, 42 (10) 1746-1751; DOI: https://doi.org/10.3899/jrheum.150232
You have access
Circulating Concentrations of the Novel Adipokine Chemerin Are Associated with Cardiovascular Disease Risk in Rheumatoid Arthritis
Patrick H. Dessein, Linda Tsang, Angela J. Woodiwiss, Gavin R. Norton and Ahmed Solomon

The Journal of Rheumatology September 1 2014, 41 (9) 1746-1754; DOI: https://doi.org/10.3899/jrheum.140122
You have access
GRAPPA 2013 Basic/Translational/Clinical Science Update: Comorbidity Monitoring
Wolf-Henning Boehncke

The Journal of Rheumatology June 1 2014, 41 (6) 1224-1226; DOI: https://doi.org/10.3899/jrheum.140175

Main menu

User menu

Search

CARDIOVASCULAR RISK

Pages

Content

Resources

Subscribers

More